Genetic Association of BSF2 Polymorphism and Susceptibility to Lung Cancer

被引:1
|
作者
Wang, Hong [1 ]
Liu, Zhandi [1 ]
机构
[1] 307 Hosp PLA, Dept Lung Canc, Affiliated Hosp, Acad Mil Med Sci,FengTai Area, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
Lung cancer; BSF2; Polymorphism; Susceptibility; INFLAMMATORY GENES; INTERLEUKIN-6; GENE; SERUM-LEVELS; TNF-ALPHA; NSAID USE; RISK; IL-6; LOCUS; CYTOKINES; VARIANTS;
D O I
10.1007/s12013-014-0147-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BSF2 polymorphism is believed to affect the transcriptional capability of the gene. Studies of lung cancer have associated BSF2 polymorphism with risk of lung cancer, only failing to identify whether this polymorphism predisposes an individual variation in the susceptibility to the malignant cancer. The primary aim of this study was to determine the association. An exhaustive literature search was conducted in the Medline and CNKI databases. Based on the data extracted from each of the included studies, we estimated the risk of lung cancer ascribed to BSF2 polymorphism by calculating ORs and its 95 % CIs. When pooling all eligible studies into the meta-analysis, we did not see any evidence suggesting there was a significant association between BSF2 polymorphism and risk of lung cancer. For the studies of Caucasian sample, the effects were exactly the same as those observed in the overall comparison. Our results suggest that BSF2 polymorphism may not predispose genetic susceptibility toward lung cancer in Caucasian populations, which nevertheless requires additional investigation.
引用
收藏
页码:1887 / 1891
页数:5
相关论文
共 50 条
  • [21] p53 codon 72 polymorphism in Taiwanese lung cancer patients:: Association with lung cancer susceptibility and prognosis
    Wang, YC
    Chen, CY
    Chen, SK
    Chang, YY
    Lin, PP
    CLINICAL CANCER RESEARCH, 1999, 5 (01) : 129 - 134
  • [22] Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer
    Adabi, Zahra
    Ziaei, Seyed Amir Mohsen
    Imani, Mahdieh
    Samzadeh, Mohammad
    Narouie, Behzad
    Jamaldini, Seyed Hamid
    Afshari, Mahdi
    Safavi, Majid
    Roshandel, Mohammad Reza
    Hasanzad, Mandana
    ARCHIVES OF MEDICAL RESEARCH, 2015, 46 (07) : 546 - 550
  • [23] An association between a NQ01 genetic polymorphism and risk of lung cancer
    Saldivar, SJ
    Wang, YF
    Zhao, H
    Shao, L
    Lin, J
    Spitz, MR
    Wu, XF
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2005, 582 (1-2) : 71 - 78
  • [24] Genetic susceptibility to lung cancer in women
    Brahmer, Julie R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S61 - S62
  • [25] Tobacco, Genetic Susceptibility and Lung Cancer
    Ankathil, Ravindran
    TOBACCO USE INSIGHTS, 2010, 3 : 1 - 15
  • [26] Is there a genetic basis for lung cancer susceptibility?
    Amos, CI
    Xu, W
    Spitz, MR
    CHEMOPREVENTION OF CANCER: A CLINICAL UPDATE, 1999, 151 : 3 - 12
  • [27] Association between the c.910A>G genetic polymorphism in XRCC1 gene and susceptibility to lung cancer in a Chinese population
    Zhang, Yong
    Ni, Huanjuan
    Cheng, Deyun
    JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI, 2013, 20 : 270 - 275
  • [28] Association between a p73 Gene Polymorphism and Genetic Susceptibility to Non-small Cell Lung Cancer in the South of China
    Wang, Shuang-Shuang
    Guo, Hai-Yan
    Dong, Lin-Li
    Zhu, Xiang-Qian
    Liang-Ma
    Li, Wen
    Tang, Jian-Xin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (23) : 10387 - 10391
  • [29] CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers
    Hosono, Hiroki
    Kumondai, Masaki
    Arai, Tomio
    Sugimura, Haruhiko
    Sasaki, Takamitsu
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 263 - 268
  • [30] Genetic polymorphism of IL-18 influences susceptibility to lung cancer in population of eastern China
    Chen, Xu
    Yao, Yanping
    Lao, Jianle
    Li, Hua
    Fu, Hailong
    Qiu, Jun
    JOURNAL OF CANCER, 2024, 15 (14): : 4604 - 4611